The “2023 Cornea Products Market Report” features a new section on neurotrophic keratitis and estimates for total NK population and NK population with access to ophthalmic care, new forecasts for epithelial recurrent erosion dystrophy by region, and a revised forecast for the total population that could benefit from a cornea transplant—with breakouts for the populations who could benefit by region, by keratoplasty type, and those that have access to ophthalmic care. It also includes a new presentation of the top 10 potential markets for cornea transplants with key metrics for each.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.